NextCure Inc.

NextCure Inc. is a biotechnology company focused on the discovery and development of novel immunomedicines aimed at treating cancer and other immune-related diseases. The company's primary function is to harness the body's immune system to combat diseases, utilizing its expertise in immuno-oncology to create innovative therapeutic solutions. NextCure employs a proprietary platform known as Functional, Integrated, NextCure Discovery in immuno-Oncology (FIND-IO) to identify and validate new drug targets. This advanced approach positions the company as a significant player in the fields of oncology and immunotherapy. Moreover, NextCure's development pipeline includes promising candidates targeting a wide range of cancer types, reflecting its commitment to expanding treatment options in oncology. The biopharmaceutical sector is highly competitive, and NextCure's strategic focus on groundbreaking immunomedicines plays a critical role in addressing unmet medical needs. Headquartered in Beltsville, Maryland, NextCure collaborates with leading research institutions and industry partners to enhance its research and development efforts, contributing to its standing in the biotechnology industry as a dynamic and innovative entity pursuing advanced cancer therapies.